Compound class:
Synthetic organic
Comment: This compound is an orally bioavailable macrocyclic inhibitor of hematopoietic progenitor kinase 1 (HPK1; MAP4K1) [3]. It reverses the negative regulatory effect of HPK1 on T-cell activation. Compound 5i synergises with anti-PD-1 checkpoint inhibition in mouse tumour models, which is suggestive of potential as an adjunct in cancer immunotherapy.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure | |
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel